Procurement Summary
Country: Ukraine
Summary: Barbiturates in Combination (Ethyl Ether of A-Bromosovaleric Acid 20 Mg, Phenobarbital 18.26 Mg, Peppermint Oil 1.42 Mg) Oral Drops of 40 Ml; Piracetam/Thiotriazoline, Solution for Injection, 100 Mg/25 Mg/M...
Deadline: 21 May 2026
Posting Date: 19 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 141592215
Document Ref. No.: UA-2026-05-18-014401-a
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: UAH 34480
CPV Classification
33600000 - Pharmaceutical products
33660000 - Medicinal products for the nervous system and sensory organs
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Barbiturates in combination (ethyl ether of a-bromosovaleric acid 20 mg, phenobarbital 18.26 mg, peppermint oil 1.42 mg) oral drops of 40 ml; Piracetam/thiotriazoline, solution for injection, 100 mg/25 mg/ml, 10 ml each; Цереблолізин розчин для ін'єкцій 215, 2 мг/мл по 2 ml; Cereblolysin solution for injection 215.2 mg/ml in 5 ml; Cereblolysin solution for injection 215.2 mg/ml in 10 ml Purchase type: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products The country of origin of the goods cannot be Russian Federation / Republic of Belarus / Islamic Republic of Iran Name Classifier and its corresponding code Quantity/Units of measurement Place of delivery Date of delivery Name DK 021:2015: 33600000-6 — Pharmaceutical products The country of origin of the product is not can be Russian Federation / Republic of Belarus / Islamic Republic of Iran Name Classifier and its corresponding code Quantity/Units of measurement Place of delivery Date of delivery Name Barbiturates in combination (ethyl ether of a-bromosovaleric acid 20 mg, phenobarbital 18.26 mg, peppermint oil 1.42 mg) oral drops 40 ml each, Piracetam/thiotriazoline, solution for injection, 100 mg/25 mg/ml, 10 ml each, Cereblolysin solution for injection 215.2 mg/ml each 2 ml, Cereblolysin solution for injection 215.2 mg/ml of 5 ml, Cereblolysin solution for injections of 215.2 mg/ml in 10 ml
Documents
Tender Notice